Cerebral Oxymetry at Elective Coronary and Valve Surgery. (Co-HLM)
This study has been completed.
Information provided by (Responsible Party):
Oslo University Hospital
First received: September 9, 2013
Last updated: October 8, 2013
Last verified: October 2013
Use of vasopressor to maintain Mean Arterial Pressure on Cardio Pulmonary Bypass can lead to decreased cerebral flow and oxygenation in individual patients and this can be detected by means of cerebral oxymetry.
Coronary Artery Disease.
Aortic Valve Stenosis.
Aortic Valve Regurgitation.
||Observational Model: Cohort
Time Perspective: Prospective
||Cerebral Oxymetry at Elective Coronary and Valve Surgery: An Observational Study Using Norepinephrine to Maintain Arterial Blood Pressure on Cardio Pulmonary Bypass.
Primary Outcome Measures:
- Cerebral oxymetry values [ Time Frame: March 2013 ] [ Designated as safety issue: No ]
| Study Start Date:
| Study Completion Date:
| Primary Completion Date:
||March 2013 (Final data collection date for primary outcome measure)
|Ages Eligible for Study:
||18 Years to 80 Years
|Genders Eligible for Study:
|Accepts Healthy Volunteers:
We want to include 50 patients, both women and men, undergo elective coronary bypass surgery or valve surgeon in CPB with moderate hypothermia.
- Patient age under 80.
- Patients should undergo elective coronary artery bypass grafting surgery (ACB) or heart valve surgery (AVR or MVR).
- The patient must be admitted at least 18 years of years.
- Damage to the frontal lobes corresponding to the area where SCO2 monitored.
- Patients in pharmacological studies.
- Patients with known intracranial vascular anomalies or cerebral aneurysms.
- Patients with known neurological disease.
- Patients with known undergone cerebral insult, TIA or carotid stenosis.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study.
To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below.
For general information, see Learn About Clinical Studies.
Please refer to this study by its ClinicalTrials.gov identifier: NCT01940874
|Oslo University Hospital
|Oslo, Norway, 0424 |
Oslo University Hospital
||Ove A. Hagen, MD
||Oslo Ùniversity Hospital
No publications provided
||Oslo University Hospital
History of Changes
|Other Study ID Numbers:
|Study First Received:
||September 9, 2013
||October 8, 2013
||Norway:National Committee for Medical and Health Research Ethics
Norway: Ministry of Health and Care Services
Keywords provided by Oslo University Hospital:
Aortic valve stenosis.
Aortic valve regurgitation.
Coronary artery disease.
Additional relevant MeSH terms:
ClinicalTrials.gov processed this record on May 20, 2015
Aortic Valve Insufficiency
Aortic Valve Stenosis
Coronary Artery Disease
Arterial Occlusive Diseases
Heart Valve Diseases
Ventricular Outflow Obstruction